Research from National Cancer Institute (NCI) Provide New Insights into Veterinary Science (Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs)

  • William Figg

Press/Media

Period26 Dec 2022

Media coverage

1

Media coverage

  • TitleResearch from National Cancer Institute (NCI) Provide New Insights into Veterinary Science (Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs)
    Media name/outletDaily Veterinary News
    Country/TerritoryUnited States
    Date26/12/22
    PersonsWilliam Figg
View all 1
View less

Related content